Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021
August 05 2021 - 4:30PM
Business Wire
Geron Corporation (Nasdaq: GERN) today announced that it will
release its second quarter and year to date 2021 financial results
after the market closes on Monday, August 16, 2021 via press
release, which will be available on the Company’s website at
www.geron.com/investors. Geron will host a conference call to
discuss the financial results as well as recent events at 4:30 p.m.
ET the same day.
A live, listen-only webcast will be available on the Company’s
website at www.geron.com/investors/events. An archive of the
webcast will be available on the Company’s website for 30 days.
Participants may access the conference call live via telephone
by pre-registering online using the following link,
http://www.directeventreg.com/registration/event/5548255. Upon
registration, a phone number, Direct Event Passcode and unique
Registrant ID will be sent via email. This information will be
needed in order to enter the conference call. Participants are
advised to pre-register at least 10 minutes prior to joining the
call.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
myeloid malignancies. The Company currently is conducting two Phase
3 clinical trials: IMerge in lower risk myelodysplastic syndromes
and IMpactMF in refractory myelofibrosis. For more information
about Geron, visit www.geron.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210805005933/en/
Olivia Bloom Chief Financial Officer investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Sep 2023 to Sep 2024